| Foreign | Local News | |
JUNE , 2023 | THE HEALTH
07
Florence acquires Zipnosis from Bright Health
HEALTHCARE enablement software company Florence , which focuses largely on workflow automation , has acquired Zipnosis , an asynchronous-first virtual care solution , from insurtech Bright Heat . The acquisition price was not disclosed .
With this , acquisition Florence expects to broaden its product offerings with both synchronous and asynchronous virtual care . The ultimate goal , the company said , is to address the issue of clinical capacity by creating a consumercentric interface that engages patients across both virtual and physical care .
“ Zipnosis ’ asynchronous telemedicine solution is the best in the industry and perfectly aligns with Florence ’ s vision to create capacity to care in physical settings ,” said Florence CEO Aniq Rahman .
What Zipnosis will do , said Florence , is boost patient
NOVARTIS Foundation and IntraHealth International launched the CARDIO4Cities Accelerator , on May 22 , at the sides of the 76th World Health Assembly .
The accelerator aims to replicate CARDIO4Cities , the cardiovascular ( CV ) population health approach pioneered and validated by the Novartis Foundation , in 30 major cities within the next three years . As a neutral broker between city governments , health experts , industry , implementing partners , funders and investors , the accelerator pledges the global community to direct action and
SK bioscience , a global innovative vaccine and biotech company committed to promoting human health from prevention to cure , announced that the company ’ s CEO , Jaeyong Ahn presented methods for equitable access of vaccine in the world at the Regionalised Vaccine Manufacturing Collaborative ( RVMC ) Side Event as a panel representing private companies .
The RVMC is a global initiative launched at the World Economic Forum ( WEF ) in May 2022 to address inequality in vaccine distribution between few rich countries and lowand middle-income countries during the Covid-19 pandemic . This year ’ s RVMC was held in line with the 76th World Health Assembly week ( May 21-30 , 2023 ).
Under the title ‘ National
accessibility and free up 99 per cent of provider work time by using intelligent adaptive interviews that enable care delivery in about 89 seconds . As a result , the company said , physicians will be able to treat more patients while allocating additional time to those with greater needs .
Zipnosis has facilitated 4.5 million patient encounters and engaged 3,500 physicians at more than 50 different top health institutions , including Ballad Health , SSM Health , the Medical University of South Carolina , and Allina Health , the company said .
The acquisition follows Florence ’ s formal launch in April ,
funding toward transforming CV population health and equity .
Projections based on initial CARDIO4Cities programs in São Paulo ( Brazil ), Dakar ( Senegal ) and Ulaanbaatar ( Mongolia ), published in PLOS Global Public Health , revealed that CARDIO4Cities was highly cost-effective , increased blood pressure controls by three times or more , and averted up to 13 per cent of strokes and 12 per cent of heart attacks within one to two years of implementation .
“ The launch of the CARDIO4Cities Accelerator is a logical next step to enable large scale when it also announced US $ 20 million in seed funding , led by Thrive Capital , Google Ventures and Salesforce Ventures .
Florence promises patients the ability to track and accelerate their healthcare journey via smartphone , update clinical information , facilitate prescription fulfilment , initiate self-discharge , and schedule follow-up appointments . The company also said its goal is to reduce costs through “ consumergrade patient experiences ” that automate staff workflows .
Zipnosis , which currently employs about 60 people , said it can increase physician capacity by 60 per cent in just 15 minutes per day .
By selling off Zipnosis , Bright Health hopes to stay afloat after overdrawing on its credit . Originally the company was tasked with securing US $ 300 million by the end of April to avoid bankruptcy , but according to a recent filing with the Securities and Exchange Commission , it managed to secure an extension through June 30 .
Transforming cardiovascular health globally
Solution for equitable access of vaccines
and Regional Health Security from mRNA to a Sustainable Regional Manufacturing Framework ’, representatives of international organisations , including the World Health Organisation ( WHO ), Coalition for Epidemic Preparedness Innovations ( CEPI ), Pan American Health Organisation ( PAHO ), Global Alliance for Vaccines replication of the CV population health approach the Novartis Foundation successfully pioneered ,” says Dr Ann Aerts , Head of the Novartis Foundation .
Philippe Guinot , chief technical officer and interim chief operating officer at IntraHealth International , says : “ Health is a human right , but for too many , it remains a dream . The CARDIO4Cities Accelerator offers a concrete path toward making that dream a reality , empowering cities to use collaboration across sectors , innovative financing , proven strategies , and real-time data to improve cardiovascular health .”
and Immunisation ( Gavi ), and African Centers for Disease Control and Prevention ( Africa CDC ), and heads of the public health administrations , attended the event .
CEO Jaeyong Ahn introduced the company ’ s key growth strategy , the “ Globalisation ” project and prerequisite conditions for achieving the vision of the RVMC during the discussion session .
The glocalisation project is one of SK bioscience ’ s core future business strategies which transfers vaccine R & D and manufacturing capabilities to the low- and middle- income countries to set up vaccine infrastructures qualifying the need in each region . Currently , SK bioscience is preparing to establish the regional vaccine hubs in the Middle East , Africa , Southeast Asia , and Latin America .
Treasure Global enhances its health and wellness e-commerce
TREASURE Global Inc ( Treasure Global ), an innovative technology solutions provider for the F & B industry , announced on May 15 an exclusive partnership with enogy , a health and wellness brand , to expand the range of products available on its e-commerce marketplace , Zstore , targeting the large and growing health and wellness industry .
As part of the partnership , enogy products will be exclusively available in the Zstore marketplace within the ZCITY app , a digital entrepreneurship platform . In addition , Treasure Global will promote enogy products to its expanding database of Zmembers , leveraging a combination of conventional and cutting-edge digital marketing strategies to quickly target ZCITY users .
Through ZCITY ‘ s AI technology , Treasure Global will customise the app ’ s product offerings to consumers ’ preferences and spending habits . In addition , the new revenue stream from enogy and other affiliate partner products sold on the ZCITY app will contribute to Treasure Global ’ s revenue growth and brand presence as it continues to expand throughout Malaysia and beyond .
“ Our partnership with enogy will expand the range of health and wellness products available to our customers , broadening the appeal of ZCITY for customers wanting to improve their wellbeing . Furthermore , by aligning with enogy ’ s existing international reach in China and regional expansion plans in Indonesia , South Korea and Japan , it will increase the brand exposure of Zstore and the ZCITY app ,” said Sam Teo , CEO of Treasure Global .
Sunrise Group among the world ’ s top 10
LEADING Chinese chemical distribution company Sunrise Group has secured a global ranking of tenth place and third place in the Asia-Pacific region on the latest ICIS Top 100 Chemical Companies list . According to its latest financial report , Ningbo-based Sunrise Group generated US $ 3.6 billion in sales .
In 2022 , the company expanded into the pharmaceutical sector , acquiring Taizhou Dachen Pharmaceutical , a firm specialising in R & D and manufacturing of pharmaceutical raw materials and intermediates such as pyrazole and sitagliptin side chain .
Taizhou Dachen Pharmaceutical generates an annual output of US $ 58 million . The deal has strengthened Sunrise Group ’ s competitive advantage within the API and intermediate market . It has also paved the way for entry into the higher-end pharmaceutical preparation market . - The Health